BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7941872)

  • 1. [The characteristics of the synthesis of specific antihemagglutinins and antihemolysins in subjects inoculated with live measles vaccine in different climatic and geographical areas].
    Novitskiĭ IA; Tikhonova NT; Mamaeva TA; Dubov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):64-8. PubMed ID: 7941872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The duration and strength of postvaccinal measles immunity].
    Bolotovskiĭ VM; Gelikman BG; Auzinia AV; Glinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):32-7. PubMed ID: 2386001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of the immune response of children in the Arctic to live measles vaccine].
    Anpilogova LV; Dubov AV; Popov VF; Iunasova TN; Leĭko AP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):51-3. PubMed ID: 3445731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The duration and intensity of measles immunity after a repeat inoculation against this infection].
    Bolotovskiĭ VM; Mikheeva IV; Gelikman BG; Auzinia AV; Glinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):45-9. PubMed ID: 2385988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measles morbidity among children inoculated against this infection].
    Bolotovskiĭ VM; Gelikman BG; Mikheev IV; Titova NS; Kikosh GV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):38-43. PubMed ID: 3705811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Macrophage transformation of mononuclear cells following primary and secondary experimental immunization with measles vaccine].
    Zakharova TR; Bolotovskiĭ VM; Titova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):72-4. PubMed ID: 2741608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transplacental measles immunity in infants in the 1st year of life].
    Bystriakova LV; Zaĭtseva RV; Kolobova LV; Pushkareva EA; Smorodinova IP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):50-2. PubMed ID: 1839342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles vaccination. VIII. The occurrence of antibodies against virus envelope components after immunization with inactivated vaccine. Effects of revaccination with live measles vaccine.
    Norrby E; Lagercrantz R
    Acta Paediatr Scand; 1976 Mar; 65(2):171-6. PubMed ID: 1258633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development and experience in the use of an immunoenzyme test system for determining specific antihemolysins in patients with measles].
    Mamaeva TA; Ponomareva AM; Tikhonova NT
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):95-8. PubMed ID: 3364085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The results of multiyear observations on the duration of the maintenance of immunity in those vaccinated and revaccinated against and recovered from measles].
    Sliusar' LI; Sokhin AA; Radomskaia FS; Degtiareva GV; Panasenko LI; Litvinova TP; Komarevskaia RV; Bol'shinskaia ZhI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):66-70. PubMed ID: 2239007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to measles virus surface polypeptides in an immunized student population before and after booster vaccination.
    Mäkelä MJ; Marusyk RG; Norrby E; Tyrrell DL; Salmi AA
    Vaccine; 1989 Dec; 7(6):541-5. PubMed ID: 2692335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological effectiveness of a booster inoculation against measles in children remaining seronegative after vaccination].
    Bolomovskiĭ VM; Gelikman BG; Titova NS; Slavnitskaia IV; Auzinia AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):100-6. PubMed ID: 6333122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The validation of the expediency of a review of the times for revaccinating children against measles].
    Rusakova EV; Bezuglova MS; Vasil'eva VI; Frank KD; Drynov ID; Filatov NN; Demskiĭ VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):51-4. PubMed ID: 1950287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serological study of postvaccinal measles immunity in the absence of a booster effect and in measles foci].
    Chudnaia LM; Fastovskaia BN; Shekhter AB; Orekhova GI; Dzhulaĭ AS
    Tr Inst Im Pastera; 1979; 53():71-5. PubMed ID: 262711
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of genetic and phenotypical factors on the efficiency of the vaccination of young children against diphtheria and measles].
    Gordeeva LA; Shabaldin AV; Semenova EM; Glushkov AN
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (2):42-6. PubMed ID: 16758897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented antibody response to live attenuated measles vaccine in children with Plasmodium falciparum parasitaemia.
    Smedman L; Silva MC; Gunnlaugsson G; Norrby E; Zetterstrom R
    Ann Trop Paediatr; 1986 Jun; 6(2):149-53. PubMed ID: 2425725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Persistence of immunity to attenuated measles live vaccine. VI. Observation on the results of revaccination with different vaccines via varied routes].
    Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):541-5. PubMed ID: 6418355
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme.
    Broliden K; Levén B; Arneborn M; Böttiger M
    Scand J Infect Dis; 1998; 30(1):23-7. PubMed ID: 9670354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.